Robert Hannan will serve as interim president and CEO following Ronald Ziegler's retirement Feb. 28. Hannan was president and CEO of Thrift Drug for 10 years until the chain was acquired by J.C. Penney and merged with Eckerd in 1997. After serving as Eckerd vice chairman during the transition, Hannan retired in 1998. He was NACDS chairman from 1993 to 1994. Ziegler will retire at the end of February "because of health reasons," NACDS announces Feb. 8. Ziegler previously said he would retire in December 2000 after a successor was named ("The Tan Sheet" Feb. 1, p. 27). However, in a series of meetings with the association board in Miami, "he concluded that it was in his best interest to initiate his retirement sooner than originally planned," NACDS says. The association emphasizes that "Ziegler and the entire board hold one another in the highest regard and in the highest terms of respect"

US President Joe Biden has invoked the Defense Production Act to ramp up COVID-19 tests and personal protective equipment. See what AdvaMed’s CEO Scott Whitaker wrote in a letter to Biden where he asked that the device industry be included in the administration’s decision-making process.

Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.